Type(s) of Cancer
Breast
Breast
Study Phase
Phase 3
Study Completion Date
September 2006
September 2006
NCT00081796Uploaded 04-29-2015
Available for Download
PDS UID: Breast_SanofiU_2004_135
A Randomized, Open-Label, Phase III Study of RPR109881 IV Every 3 Weeks Versus Capecitabine (Xeloda) Tablets Twice Daily for 2 Weeks in 3-Week Cycles in Patients With Metastatic Breast Cancer Progressing After Taxanes and Anthracycline Therapy
PDS UID: Breast_Multipl_2004_414Go to Study
Enhancing the Analytic Capacity of Breast_SanofiU_2004_135 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
Files:
PROTOCOLsanofi_XRP9881_EFC6089_CRF_redacted.pdf
CRFsanofi_XRP9881_EFC6089_Protocol_Redacted.pdf
DATA DICTIONARYsanofi_XRP9881_EFC6089_datasphere_data_definition.xls
DATA SUMMARYProc Contents Data Dictionary PDS135.pdf
DATA (COMPARATOR ARM)sanofi_xrp9881_efc6089_datasets_and readme.zip